Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research

202133 citationsJournal Articlegreen Open Access

Authors

Karine Dubé · University of North Carolina at Chapel Hill

John Kanazawa · University of North Carolina at Chapel Hill

Lynda Dee · AIDS United

Jeff Taylor · Advisory Board Company (United States)

Danielle Campbell · Advisory Board Company (United States)

Brandon Brown · University of California, Riverside

Mallory O. Johnson

Abstract

<b>Conclusion:</b> While there is no way to completely eliminate the risk of HIV transmission to sexual partners during ATIs, HIV cure trialists and sponsors should consider the ethical concerns related to the sexual partners of ATI participants. Doing so is essential to ensuring the welfare of participants, their partners and the trustworthiness of research.

Topics & Keywords

HIV/AIDS Research and Interventions HIV, Drug Use, Sexual Risk Ethics in Clinical Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: HIV Research & Clinical Practice

Volume 22, Issue 1, pp. 14-30

DOI: 10.1080/25787489.2021.1902116

Field-Weighted Citation Impact: 1.56

Command Palette